Spinal Singularity treats first patient with Connected Catheter

Spinal Singularity declared that the first patient has been treated with the Connected Catheter which is an innovative, smart catheter system designed for adult males with Chronic Urinary Retention and/or Neurogenic Lower Urinary Tract Dysfunction.

The Clinical Feasibility Study is being led by Dr. Ernest Agatstein, MD, an expert Urologist and co-founder of West Coast Urology.

Dr. Agatstein who has served as a Scientific Advisor to Spinal Singularity since 2015, when the company was founded, states “It has been amazing to watch the Connected Catheter develop and mature over the past couple of years.  What started as a simple idea being relentlessly pursued by passionate founders is now a real medical device that has the potential to radically improve the quality of life for millions of catheter users. I am honored to have treated the first patient in the US with this device and look forward to collecting more data during this study.”

Spinal Singularity has also secured IRB approval to expand the study at two additional sites.  Dr. Ian Lee Goldman, MD will lead efforts at the Arizona Center for Cancer Care (AZCCC) in Surprise, AZ and Dr. Sreenivas Vemulapalli, MD will be the principal investigator at Tri-Valley Urology in Murrieta, CA.